Unknown

Dataset Information

0

Disposition of the Emerging Brominated Flame Retardant, 2-Ethylhexyl 2,3,4,5-Tetrabromobenzoate, in Female SD Rats and Male B6C3F1 Mice: Effects of Dose, Route, and Repeated Administration.


ABSTRACT: 2-Ethylhexyl-2,3,4,5-tetrabromobenzoate (EH-TBB; MW 549.92?g/mol; CAS 183658-27-7) is a brominated component of flame retardant mixtures used as substitutes for some PBDEs. EH-TBB is added to various consumer products, including polyurethane foams, and has been detected in humans. The present study characterized the fate of EH-TBB in rodents. [14C]-labeled EH-TBB was absorbed, metabolized, and eliminated via the urine and feces following single administrations of 0.1-100 µmol/kg (?0.05-55?mg/kg) or repeated administration (0.1 µmol/kg/day × 5-10 days) by gavage to female Hsd:Sprague DawleySD (SD) rats. Cumulative excretion via feces increased (39-60%) with dose (0.1-10 µmol/kg) with corresponding decreases in urinary excretion (54 to 37%) after 72?h. Delayed excretion of [14C]-radioactivity in urine and feces of a 100 µmol/kg oral dose was noted. Recovery was complete for all doses by 72?h. IV-injected rats excreted more of the 0.1 µmol/kg dose in urine and less in feces than did gavaged rats, indicating partial biliary elimination of systemically available compound. No tissue bioaccumulation was found for rats given 5 oral daily doses of EH-TBB. Parent molecule was not detected in urine whereas 2 metabolites, tetrabromobenzoic acid (TBBA), a TBBA-sulfate conjugate, and a TBBA-glycine conjugate were identified. EH-TBB and TBBA were identified in extracts from feces. Data from gavaged male B6C3F1/Tac mice indicated minimal sex- or species differences are likely for the disposition of EH-TBB. Approximately 85% of a 0.1 µmol/kg dose was absorbed from the gut. Overall absorption of EH-TBB is expected to be even greater at lower levels.

SUBMITTER: Knudsen GA 

PROVIDER: S-EPMC5139073 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4583349 | BioStudies
2014-01-01 | S-EPMC4154220 | BioStudies
2019-01-01 | S-EPMC6820923 | BioStudies
2020-01-01 | S-EPMC7028346 | BioStudies
2020-01-01 | S-EPMC7584751 | BioStudies
2016-01-01 | S-EPMC4980246 | BioStudies
2019-01-01 | S-EPMC6804416 | BioStudies
2014-01-01 | S-EPMC4813726 | BioStudies
2016-01-01 | S-EPMC5090262 | BioStudies
2017-01-01 | S-EPMC5572725 | BioStudies